List view / Grid view

Yochi Slonim (Anima Biotech)

 

article

The future of mRNA biology and AI convergence

In the rapidly evolving landscape of mRNA biology and artificial…

21 December 2023 | By

In the rapidly evolving landscape of mRNA biology and artificial intelligence (AI), Anima Biotech stands at the forefront, a unique approach that reshapes our understanding of diseases and transforms the drug discovery process. mRNA biology holds immense potential with RNAi drugs in the market and mRNA vaccines showing promise, particularly…

article

Seeing the light – visualising protein translation in real time

Non-invasive imaging has played an increasing role in drug discovery…

4 June 2020 | By

Non-invasive imaging has played an increasing role in drug discovery and development processes. Nikki Withers spoke with Yochi Slonim, who discusses a novel technology that leverages FRET signals for the discovery of small molecule drugs that selectively control mRNA translation in a novel target space.